{"schema_version":"secwatch.filing_event.v1","accession":"0001728117-21-000092","form_type":"8-K","ticker":"GOSS","cik":"0001728117","company_name":"Gossamer Bio, Inc.","filed_at":"2021-09-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.401732+00:00","generated_at":"2026-06-29T02:22:40.533488+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Gossamer Bio promotes CFO Bryan Giraudo to also serve as COO","bullets":["Bryan Giraudo appointed COO effective Sept 16, 2021, while remaining CFO.","Annual base salary increased to $460,000; target bonus raised to 45% of salary.","Granted option for 150,000 shares under 2019 Equity Incentive Plan; vests over 4 years.","Severance enhanced: 9 months base salary (12 months upon change-in-control) plus bonus and COBRA.","Giraudo joined Gossamer in May 2018 as CFO; previously Senior MD at SVB Leerink."],"urls":{"canonical":"https://secwatch.observer/filing/0001728117-21-000092","json":"https://secwatch.observer/filing/0001728117-21-000092.json","markdown":"https://secwatch.observer/filing/0001728117-21-000092.md","text":"https://secwatch.observer/filing/0001728117-21-000092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000092/0001728117-21-000092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000092/goss-20210916.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T02:22:40.533488+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d2784202cc","claim":"Bryan Giraudo changed role as Chief Operating Officer/Chief Financial Officer at Gossamer Bio, Inc..","evidence_excerpt":"Effective September 16, 2021, Bryan Giraudo was promoted to Chief Operating Officer/Chief Financial Officer of Gossamer Bio, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000092/0001728117-21-000092-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Operating Officer/Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}